|
New asthma treatment threatens inhaler companies
In-PharmaTechnologist.com A new oral medication for asthma sufferers could wipe out half of all business for inhaler manufacturers. Researchers, lead by Respiratory Research's Professor David Price, completed a two-year long pragmatic trial into … |
View full post on asthma – Google News